VPC-16606 is a selective inhibitor targeting the activation function 2 (AF2) domain of estrogen receptor alpha (ERalpha). VPC-16606 blocks the interaction between ERalpha and coactivators, inhibits the activity of both wild-type and clinically drug-resistant mutant ERalpha, and exerts inhibitory effects on hormone-resistant breast cancer cells. VPC-16606 can be used in breast cancer research[1].
Molekulargewicht:
344.81
CAS Nummer:
[2027540-49-2]
Formel:
C17H13ClN2O2S
Target-Kategorie:
Estrogen Receptor/ERR
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
